← Back to headlines
Morgan Stanley Raises BioNTech SE Price Target
Morgan Stanley has slightly raised its price target for BioNTech SE (BNTX) as it updates its biopharma coverage models.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Cyclospora Outbreak Linked to Iceberg Lettuce Expands to Three Additional States
3h ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
5h ago
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
9h ago
West Nile Virus Outbreaks Spread Across Greece and North Macedonia
10h ago